{"database": "lobbying", "table": "lobbying_activities", "rows": [[1807018, "6d91916a-a548-46da-b9de-a9cc25c44469", "Q1", "FOLEY HOAG LLP", 79610, "GILEAD SCIENCES INC", 2016, "first_quarter", "MMM", "Ryan White Care Act reauthorization; Hepatitis C (HCV) policy; PEPFAR reauthorization; HIV/AIDS research, testing and treatment; Affordable Care Act implementation; HCV screening and linkage to care programs; House Committee on Energy & Commerce 21st Century Cures initiative.", "HOUSE OF REPRESENTATIVES,SENATE", 25200, null, 0, 0, "2016-04-13T19:18:48.277000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1807018"], "units": {}, "query_ms": 0.32526999711990356, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}